Reframing the narrative on psychedelics, how alcohol is the most destructive drug in society, and the debate on legalising drugs, leading expert in psychedelic research, Dr Rayyan Zafar joins me to change your perspective on this fascinating topic.With only 30% of the population actually responding to anti-depressants, Dr Zafar reveals the potential of psychedelics as an alternative to anti-depressants [17.53], the REAL reason why drugs are illegal [35.48] and explains how gambling addictions are a serious mental health illness [48:44].This is an eye-opening conversation aiming to really challenge your perception of these subjects.To find out more on Dr Zafar you can find him on:Instagram: @rayyanzaf @icaro.eventsTwitter: @RayyanZafar6Websites: https://www.imperial.ac.uk/psychedelic-research-centre/ // https://www.drugscience.org.ukIf you enjoyed this episode, please click follow - we have so many great guests like this one, you won't want to miss out!You can also follow us on Instagram and Tiktok @greatcompanypodcastTHE CREDITS:Exec Producer: Jemima RathboneAssistant Producer: Gurlina HeerBooking: Ben JohnsVideo: Jamie GilbertGreat Company is an original podcast from JamPot Hosted on Acast. See acast.com/privacy for more information.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare